Pouring money into emerging markets hasn't been enough to generate the type of return that Medtronic CEO Omar Ishrak has been promising.
Medtronic has a bit of a growth problem in emerging markets, and throwing money at it isn't making it go away.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oZlefG
Cap comentari:
Publica un comentari a l'entrada